Comparison between Accretion Nutraveda IPO and Maxwell Engineering Solutions IPO.
Accretion Nutraveda IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Maxwell Engineering Solutions IPO is a SME Bookbuilding proposed to list at BSE SME.
| Accretion Nutraveda IPO | Maxwell Engineering Solutions IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Sobhagya Capital Options Pvt.Ltd. | Religo Capital Advisors Pvt.Ltd. |
| Registrar | Kfin Technologies Ltd. | Kfin Technologies Ltd. |
| Market Maker | Sunflower Broking Pvt.Ltd. | |
| DRHP | DRHP  | DRHP |
| RHP | RHP | |
| Final Prospectus | Final Prospectus | |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL |
The total issue size of Accretion Nutraveda IPO is up to ₹23.53 Cr whereas the issue size of the Maxwell Engineering Solutions IPO is up to ₹0.00 Cr. The final issue price of Accretion Nutraveda IPO is ₹129.00 per share and of Maxwell Engineering Solutions IPO is .
| Accretion Nutraveda IPO | Maxwell Engineering Solutions IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹122.00 per share | |
| Issue Price (Upper) | ₹129.00 per share | |
| Issue Price (Final) | ₹129.00 per share | |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 1000 shares | |
| Fresh Issue Size | 18,24,000 shares | 36,50,000 shares |
| Fresh Issue Size (Amount) | up to ₹23.53 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 18,24,000 shares | 36,50,000 shares |
| Issue Size Total (Amount) | up to ₹23.53 Cr | up to ₹0.00 Cr |
Accretion Nutraveda IPO opens on Jan 28, 2026, while Maxwell Engineering Solutions IPO opens on . The closing date of Accretion Nutraveda IPO and Maxwell Engineering Solutions IPO is Jan 30, 2026, and , respectively.
| Accretion Nutraveda IPO | Maxwell Engineering Solutions IPO | |
|---|---|---|
| Anchor Bid Date | Jan 27, 2026 | |
| Issue Open | Jan 28, 2026 | |
| Issue Close | Jan 30, 2026 | |
| Basis Of Allotment (Tentative) | Feb 02, 2026 | |
| Initiation of Refunds (Tentative) | Feb 03, 2026 | |
| Credit of Share (Tentative) | Feb 03, 2026 | |
| Listing date (Tentative) | Feb 04, 2026 | |
| Anchor Lockin End date 1 | Mar 03, 2026 | |
| Anchor Lockin End date 2 | May 02, 2026 |
Accretion Nutraveda IPO P/E ratio is 26.27, as compared to Maxwell Engineering Solutions IPO P/E ratio of .
| Accretion Nutraveda IPO | Maxwell Engineering Solutions IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated)Maxwell Engineering Solutions Ltd.'s revenue increased by 108% and profit after tax (PAT) rose by 190% between the financial year ending with March 31, 2025 and March 31, 2024.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100 | 100 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 73.48 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 26.27 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹93.40 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 81.22 | 112.35 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 36.98 | 53.29 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.72 | 0.66 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹4.91 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 48.85 | 70.56 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Accretion Nutraveda IPO Retail Individual Investors (RII) are offered 6,40,000 shares while in Maxwell Engineering Solutions IPO retail investors are offered 6,40,000 shares. Qualified Institutional Buyers (QIB) are offered 3,64,000 shares in Accretion Nutraveda IPO and 0 shares in Maxwell Engineering Solutions IPO.
| Accretion Nutraveda IPO | Maxwell Engineering Solutions IPO | |
|---|---|---|
| Anchor Investor Reservation | 5,44,000 shares | 0 shares |
| Market Maker Reservation | 96,000 shares | 0 shares |
| QIB | 3,64,000 shares | 0 shares |
| NII | 2,76,000 shares | 0 shares |
| RII | 6,40,000 shares | 0 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 18,24,000 shares | 0 shares |
Accretion Nutraveda IPO subscribed 1.29x in total, whereas Maxwell Engineering Solutions IPO subscribed .
| Accretion Nutraveda IPO | Maxwell Engineering Solutions IPO | |
|---|---|---|
| QIB (times) | 1.01x | |
| NII (times) | 2.08x | |
| Big NII (times) | 1.95x | |
| Small NII (times) | 2.33x | |
| RII (times) | 2.19x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.29x |
